Jubilant Pharmova

Update in progress

JUBLPHARMA.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Jubilant Pharmova Limited is an integrated pharmaceutical company serving India, the Americas, Europe and beyond. It operates six segments: Radiopharma; Allergy Immunotherapy; CDMO Sterile Injectables; Generics; CRO/CMO; and Proprietary Novel Drugs. It provides radiopharmaceuticals, diagnostic devices, sterile fill-finish manufacturing, generic medicines, drug discovery and APIs, and patient-focused biopharmaceuticals for oncology and autoimmune diseases. Formerly Jubilant Life Sciences, renamed in 2021. Based in Noida, India, since 1978.

Company score

Sentiment: 0.30; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -0.03; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.27; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.01; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.07; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.19; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive